Home
Mundipharma Australia

Mundipharma Australia Market Share Analysis for July 2026

Mundipharma-au

Industry: N/A

Domainmundipharma.com.au

Year Founded--

Employees51 - 200

Annual Revenue$15M - $25M

Mundipharma Australia

Mundipharma Australia (including company regionals)

mundipharma.com.au

See more website traffic and engagement information

Mundipharma Australia Revenue up to July 2026 is 15M - 25M

revenue generated by Mundipharma Australia top domains

Mundipharma Australia top domains revenue over 3 years

Revenue for Mundipharma Australia top domains

mundipharma.com.au15M - 25M

See more with Sales Intelligence

Total visits to Mundipharma Australia's top domains

Understand Mundipharma Australia market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Mundipharma Australia's top domains

Analyze Mundipharma Australia engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Mundipharma Australia's top domains

See how Mundipharma Australia keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Mundipharma Australia top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Mundipharma Australia

These are the website technologies, by industry, used by Mundipharma Australia top domains

Content Management System (3)

WordPress

Email Services (3)

Microsoft Exchange Online

Widget (3)

Twemoji

Audio Video Media (2)

YouTube

More Technologies

8

See all

News & Signals from Mundipharma Australia

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsBioCryst Pharmaceuticals, Inc. partners with Mundipharma.BioCryst has a worldwide partnership with Roche for the development and commercialization BCX-4208, and is collaborating with Mundipharma for the development and commercialization of Fodosine in markets across Europe, Asia, Australia and certain neighboring countries.

NewsMundipharma had issues with 24 notices of violation on Dec 17th '19.In a statement last week, the TGA said it had issued 24 notices of violation against Mundipharma after determining that its advertising of Targin to healthcare professionals "was misleading, unbalanced and otherwise inaccurate" , and thereby violated the pharmaceutical promotion requirements set out in the code of conduct by the industry regulator Medicines Australia.

NewsMundipharma launches Nyxoid to help meet a clear clinical need.“Mundipharma Australia introduced Nyxoid to help meet a clear clinical need.”